Medtech Industry Lobby Group, AdvaMed, Lauds User Fee Return, New $91 Million Funding For The FDA

Medtech industry lobbying group AdvaMed offered high praise for the federal government's 2014 omnibus appropriations legislation, which restored important funding for the FDA.

The bill returned to the agency about $85 million in collected user fees that had been locked away due to the federal sequester, funds that medical device and drug companies pay for applications for FDA review.

Help employers find you! Check out all the jobs and post your resume.